What's new with Low-titer Group O Whole Blood? Dr. Mark Yazer returns to give us the latest.

Dr. Mark Yazer

Dr. Mark Yazer

Dr. Mark Yazer

Dr. Mark Yazer

About My Guest:

Dr. Mark Yazer graduated from medical school at the University of Ottawa in 2000 and completed his residency in hematological pathology at the University of Alberta in 2004. He is currently a Professor of Pathology at the University of Pittsburgh, and an associate medical director of the centralized transfusion service in Pittsburgh. He is also an adjunct Professor of Clinical Immunology at the University of Southern Denmark, and a visiting Professor of Pathology at Tel Aviv University. He has published over 250 peer reviewed papers, and is an associate editor of the journals Transfusion Medicine and Hematology. He is on the editorial board of 4 other journals. He is the co-chairman of the THOR-AABB working group. He has received grant funding from the American National Institutes of Health, the American Department of Defense, and the American military based DARPA group. He is currently a co-principal investigator of NIH R01 and R34 grants and is a collaborator on two Department of Defense grants.

Quick quiz:

Insert H5P shortcode for quiz

DISCLAIMER: The opinions expressed on this episode are those of my guest and I alone, and do not reflect those of the organizations with which either of us is affiliated. Neither Dr. Yazer nor I have any relevant financial disclosures.

Further Reading:

Thanks to:

Music Credit

Music for this episode includes "Cuando te invade el temor" and "Reflejo," both by Mar Virtual via the Free Music Archive. Click the image below for permissions and license details.
Creative Commons license and link